Navigation Links
Call for Nominations for the 2009 C.A.R.E. Pharmacy Award
Date:6/1/2009

Eisai Inc. and the Alzheimer's Association Support Award to Recognize Critical Role of Pharmacists in Alzheimer's Care

WOODCLIFF LAKE, N.J., June 1 /PRNewswire/ -- Eisai Inc., in coordination with the Alzheimer's Association, calls on individuals with Alzheimer's disease and their caregivers across America to nominate local pharmacists for the 2009 C.A.R.E. (Commitment to Alzheimer's. Recognition of Excellence.) Pharmacy Award. This award recognizes the vital role that pharmacists play in helping as many as 5.3 million Americans living with Alzheimer's disease and their 10 million caregivers.(1)

Now in its ninth year, the C.A.R.E. Pharmacy Award reflects Eisai's human health care (hhc) mission, which regards patients and their families as the most important participants in the health care process. The C.A.R.E. Pharmacy Award is one way for people with the disease and caregivers to acknowledge the extraordinary efforts of community pharmacists and their impact on the lives of people affected by Alzheimer's disease.

"Alzheimer's is a disease that affects both patients and their caregivers, and Eisai's commitment to the patient and caregiver communities is unwavering," said Cynthia Schwalm, President of Eisai Inc. "We recognize the integral role that community pharmacists play in each patient's treatment and care, providing ongoing monitoring, counseling and support. The C.A.R.E. Pharmacy Award allows us to acknowledge their efforts and showcase best practices in caregiving techniques. We are proud to be working with the Alzheimer's Association to honor the extraordinary contributions of pharmacists who are making a difference in the lives of people affected by Alzheimer's disease."

In addition to being recognized, the winning pharmacist's local Alzheimer's Association chapter will receive a $1,500 donation for its vital support programs. Another $1,500 donation will go to the Alzheimer's Association chapters located in the areas from which the most nominations are submitted.

"The Alzheimer's Association is excited to partner again with Eisai to recognize pharmacists who actively participate as part of the team of care providers for those with Alzheimer's disease," said Elizabeth Gould, MSW, director of quality care programs for the Alzheimer's Association. "We commend pharmacists who take the time to build relationships with their patients living with Alzheimer's and their caregivers, helping to educate them about Alzheimer's disease and enhancing the support they receive."

How to Nominate a Pharmacist

Alzheimer's patients and caregivers can nominate pharmacists through September 2009 by visiting www.carepharmacyaward.com. To be eligible, nominees must be licensed pharmacists involved in activities within the last year that have helped people with Alzheimer's disease, and these activities must have had a positive effect on patients and/or their families. A full description of the award and nomination criteria can be found at www.carepharmacyaward.com.

The winning pharmacist will be selected in October from the nominee pool by a panel of three judges. One judge is a director at the Alzheimer's Association's national office. The other two judges are past winners of this award. Each has spent more than 20 years improving the care of people with Alzheimer's disease through educational, advocacy and caregiver support programs.

About Eisai Inc.

Eisai Inc. is a U.S. pharmaceutical subsidiary of Eisai Co., Ltd., a research-based human health care (hhc) company that discovers, develops and markets products throughout the world. Eisai focuses its efforts in three therapeutic areas: neurology, gastrointestinal disorders and oncology/critical care. Established in 1995 and ranked among the top-20 U.S. pharmaceutical companies (based on retail sales), Eisai Inc. began marketing its first product in the United States in 1997 and has rapidly grown to become an integrated pharmaceutical business with fiscal year 2008 (year ended March 31, 2009) sales of approximately $3.7 billion, including the results of the acquisition of MGI PHARMA, INC.

Eisai Inc. employs approximately 1,900 people at its headquarters in Woodcliff Lake, NJ, at its state-of-the-art pharmaceutical production and formulation research and development facility in Research Triangle Park, NC, and in the field. For more information about Eisai, please visit www.eisai.com.

About the Alzheimer's Association

The Alzheimer's Association is the leading voluntary health organization in Alzheimer's research, care and support. Our mission is to eliminate Alzheimer's disease through the advancement of research, provide and enhance care and support for all affected, and reduce the risk of dementia through the promotion of brain health. Our vision is a world without Alzheimer's. For more information, visit www.alz.org.

Reference: 1. Alzheimer's Association. Alzheimer's Disease Facts and Figures. 2009:10,65.


'/>"/>
SOURCE Eisai Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Prix Galien USA Now Accepting Nominations for Premiere Biopharmaceutical Industry Award
2. Deadline Extended for Nominations for Jay and Rose Phillips Awards and Phillips Caregiver Award
3. Open Call for Nominations for the Sixth Annual TIAA-CREF Distinguished Medical Educator Award
4. Courage Center Now Accepting Nominations for Jay and Rose Phillips Awards and Phillips Caregiver Award
5. 2009 Prix Galien USA Now Accepting Nominations for Top Prize in Biopharmaceutical Research and Development
6. Pennsylvania Governor Rendell Announces Nominations
7. Cherokee Inspired Comfort Awards Program Call for Nominations
8. GBC Seeks Nominations for Fourth Annual Bioscience Awards
9. 12th Annual 40-Under-Forty Achievement Awards Call For Nominations
10. Eisai Inc. and the North American Thrombosis Forum (NATF)* Introduce the DVTeamCare(TM) Hospital Award and Call for Nominations
11. Deadline Extended to Submit Nominations for Depression Awards Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... June 27, 2016 , ... ... technology to revolutionize the emergency ambulance transport experience for the millions of people ... how Uber has disrupted the taxi industry through the use of technology. Now, ...
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A ... 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the ... history as home to some of the world’s leading providers of cereal and other ...
(Date:6/26/2016)... ... , ... Brent Kasmer, a legally blind and certified personal trainer is helping to develop a ... fitness app plans to fix the two major problems leading the fitness industry today:, ... type program , They don’t eliminate all the reasons people quit their exercise ...
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... ... , ... First Choice Emergency Room , the largest network of independent ... Director of its new Mesquite-Samuell Farm facility. , “We are pleased to announce ... Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. , ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/23/2016)... -- Any dentist who has made an implant supported denture ... of them do not even offer this as a viable ... costs involved. And those who ARE able to offer that ... cost that the majority of today,s patients would not be ... , founder of Dental Evolutions Inc. and inventor of Implanova ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: